How Korean Pharma Firms Reacted to Innovation Deregulation!

Explore how Korea’s 2023 deregulation policy sparked changes in drug development, especially for incrementally modified drugs. This video breaks down how large pharmaceutical companies responded with bold R&D investments, while smaller firms took a more cautious stance. Discover why the success of pharmaceutical innovation is tied not just to policy shifts, but to each company’s willingness to adapt and take risks. Gain insights into the evolving landscape of Korea’s pharma industry and what it means for future medical advancements. If you found this analysis helpful, please like and share to reach others interested in pharmaceutical innovation and policy.

Website: innovationtechnologist.com Contact: contact@innovationtechnologist.com Nomination: innovationtechnologist.com/award-n...

#sciencefather #researchawards #DrugDevelopment #KoreaPharma #Professor, #Lecturer, #Scientist, #Scholar, #Researcher, #Analyst, #Engineer, #Technician, #Coordinator, #Specialist, #Writer, #Assistant, #Associate, #Biologist, #Chemist, #Physicist, #Statistician, #DataScientist, #Consultant, #Coordinator, #ResearchScientist

Comments